[Regulatory effect of electroacupuncture at "Neiguan" (PC6) and "Zusanli" (ST36) with different intensities on autonomic nerves and cardiac function after myocardial ischemia].

Researchers investigated how electroacupuncture (EA) at different intensities affects heart function and nervous system activity after heart attacks in rats. The study examined two acupuncture points: Neiguan (PC6) on the inner forearm and Zusanli (ST36) on the leg. Forty rats were divided into control and myocardial ischemia (heart attack) groups. Researchers tested three different electrical stimulation strengths (0.5, 1.5, and 3 mA) and measured heart function, heart rate, and nerve activity. The results showed that different acupuncture points require different stimulation intensities for optimal benefit. For PC6, the best intensity was 1.5 mA, which increased both sympathetic and vagus nerve activity and improved several heart function measures including stroke volume, cardiac output, and heart rate variability. For ST36, the optimal intensity was 3 mA, which primarily increased sympathetic nerve activity and improved cardiac output. The researchers then surgically disconnected the autonomic nerves in some rats and found that electroacupuncture no longer improved heart function, proving that EA works specifically through the autonomic nervous system. This research helps explain how acupuncture affects the heart after injury and suggests that choosing the right stimulation intensity for each acupuncture point is important for therapeutic success. If you're considering acupuncture treatment for heart-related conditions, consult with a licensed acupuncturist who can customize treatment parameters to your specific needs.

This study established optimal EA intensities for cardiac function regulation post-myocardial ischemia in rats (n=40). Using LAD ligation to induce MI, researchers assessed autonomic nerve discharge, heart rate variability, and hemodynamic parameters. Key findings: PC6 showed optimal efficacy at 1.5 mA, significantly increasing sympathetic and vagal nerve discharge, HRV, and cardiac output parameters (SV, SW, CO; P<0.001). ST36 demonstrated optimal response at 3 mA, primarily elevating sympathetic discharge and cardiac output measures (P<0.01). Autonomic denervation experiments confirmed that EA's cardioprotective effects require intact autonomic innervation. Model validation included ST-segment elevation, reduced EF/FS, and elevated CVF. Clinical implications: Point-specific EA intensity optimization may enhance treatment outcomes in cardiovascular applications. The mechanistic confirmation of autonomic mediation supports traditional indications for PC6 in cardiac conditions and suggests differentiated needling parameters based on anatomical location and therapeutic goals.